This article presents a case of an 85-year-old male who underwent tr transcatheter edge-to-edge repair (teer) for treatment of symptomatic moderate-to-severe functional mitral regurgitation (mr).The patient has a history of chronic kidney disease, cerebral hemorrhage, and endovascular treatment for an iliac aneurysm was hospitalized for hf five times.Two nt mitraclip second generation were implanted with no reported issue, reducing mr to trivial.Three months after the procedure, the patient returned with lumbar pain lasting for approximately one week.The patient's laboratory tests showed worsening of his renal function and a high inflammatory reaction of unknown origin.The patient was started on antibiotic therapy, which included vancomycin and ceftriaxone.On day 3, the patient experienced fever (maximum of 37.8°c) and his blood culture was positive for methicillin-resistant staphylococcus aureus.On day 4, the patient suddenly complained of left-side dominant hemiparesis, resulting in multiple strokes evaluated by magnetic resonance imaging.On day 10, a repeated blood culture was positive again for the same agent; therefore, we evaluated the mitral valve by transesophageal echocardiography with a suspicion of invective endocarditis (ie).Imaging results showed a 16 × 14mm unstable vegetation attached to the medial clip.On day 10, the patient was scheduled to undergo surgical mitral valve replacement; however, he presented with melena and a serious disturbance of consciousness.Surgical intervention was discontinued, and the patient succumbed to multiorgan failure.No additional information was provided.Details are listed in the attached article titled, ¿infective endocarditis after transcatheter edge-to-edge repair for severe mitral regurgitation; a case report and a systematic review¿.
|
The device was not returned for analysis.The lot history record (lhr) review was not performed because this incident was based on an article review and no lot information was provided.Based on available information, the cause of the reported pain associated with lumbar pain, the reported renal failure (treatment with medication(s)) associated with worse renal function, the reported infection, the reported mitral valve insufficiency/ regurgitation (recurrent mr), the reported paresis associated with hemiparesis, the reported cerebrovascular accident associated with stroke, the reported endocarditis, the reported syncope/fainting associated with disturbance of consciousness, the reported multiple organ dysfunction syndrome (dysfunction) associated with multiorgan failure, and the reported death / expired, could not be determined.The reported patient effects of death, endocarditis, cerebrovascular accident, renal failure, multiorgan failure, pain, infection, and mitral regurgitation, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported hospitalization and medication required were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.B2, b3, d6: dates estimated.D4: the udi number is not known as the part and lot number were not provided.Attachment: article titled, "infective endocarditis after transcatheter edge-to-edge repair for severe mitral regurgitation; a case report and a systematic review"na.
|